![Apixaban triumphs over aspirin for stroke prevention in patients with atrial fibrillation | Nature Reviews Cardiology Apixaban triumphs over aspirin for stroke prevention in patients with atrial fibrillation | Nature Reviews Cardiology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrcardio.2011.31/MediaObjects/41569_2011_Article_BFnrcardio201131_Figa_HTML.jpg)
Apixaban triumphs over aspirin for stroke prevention in patients with atrial fibrillation | Nature Reviews Cardiology
![AUGUSTUS - Antithrombotic regimens including apixaban vs warfarin, & aspirin vs placebo, in patients with AFib plus PCI &/or ACS — NERDCAT AUGUSTUS - Antithrombotic regimens including apixaban vs warfarin, & aspirin vs placebo, in patients with AFib plus PCI &/or ACS — NERDCAT](https://images.squarespace-cdn.com/content/v1/56a0651bbe7b96af3e170173/1558559384490-6H4ZCHRUTBPLWPA9JDW2/apixaban+vs+warfarin.png)
AUGUSTUS - Antithrombotic regimens including apixaban vs warfarin, & aspirin vs placebo, in patients with AFib plus PCI &/or ACS — NERDCAT
![Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial - The Lancet Neurology Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial - The Lancet Neurology](https://www.thelancet.com/cms/attachment/11064ab7-590c-4e3c-bf44-87df147d66be/gr1_lrg.jpg)
Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial - The Lancet Neurology
![Low-dose aspirin does not reduce adverse heart, lung outcomes in stable COVID patients: study- McKnight's Long-Term Care News Low-dose aspirin does not reduce adverse heart, lung outcomes in stable COVID patients: study- McKnight's Long-Term Care News](https://www.mcknights.com/wp-content/uploads/sites/5/2019/07/RM_aspirin_GettyImages-a0001-000015_2000x1125.jpg)
Low-dose aspirin does not reduce adverse heart, lung outcomes in stable COVID patients: study- McKnight's Long-Term Care News
![Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5) - ScienceDirect Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109719354002-fx1.jpg)
Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5) - ScienceDirect
![Navigating the New Era: Landmark Clinical Trials on Eliquis (Apixaban) for Anticoagulation in Atrial Fibrillation - Visualmed Navigating the New Era: Landmark Clinical Trials on Eliquis (Apixaban) for Anticoagulation in Atrial Fibrillation - Visualmed](https://i0.wp.com/www.visualmed.org/wp-content/uploads/2023/04/AVERROES.jpg?fit=741%2C1368&ssl=1)
Navigating the New Era: Landmark Clinical Trials on Eliquis (Apixaban) for Anticoagulation in Atrial Fibrillation - Visualmed
![Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke](https://www.ahajournals.org/cms/asset/ae1d4f62-1d89-45e6-a77e-177b70848cd3/3291fig03.jpeg)
Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke
![Understanding Your Options When Taking Aspirin and Other Antiplatelet Drugs | American Heart Association Understanding Your Options When Taking Aspirin and Other Antiplatelet Drugs | American Heart Association](https://www.heart.org/-/media/Images/Health-Topics/Consumer-Healthcare/Answers-By-Heart/DAPT-ABH-sheet.jpg)
Understanding Your Options When Taking Aspirin and Other Antiplatelet Drugs | American Heart Association
![When Should Therapeutic Anticoagulation Be Restarted Following Major Head and Neck Surgery? - ENTtoday When Should Therapeutic Anticoagulation Be Restarted Following Major Head and Neck Surgery? - ENTtoday](https://www.enttoday.org/wp-content/uploads/2018/08/ENT_0818_pg6a.png)